1-15 of 147
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Steven Fishbane, MD
Nancy Helou, PhD
When Itching Hurts: Quality of Life Disruption in CKD-aP
MinuteCE®When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
- advertisement
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
MinuteCE®From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Reading Between the Lines: What PROMs Reveal About Itch
MinuteCE®Reading Between the Lines: What PROMs Reveal About Itch
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®What You Don’t See: A Patient’s View of Living with CKD-aP
Steven Fishbane, MD
Nancy Helou, PhD
Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®Winning the CKD-aP Battle: A United Physician-Nurse Front
Steven Fishbane, MD
Nancy Helou, PhD
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CENo Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD
Katherine Tuttle, MD
- advertisement
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
CME/CEOptimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Jörg Latus, MD
Sayna Norouzi, MD
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
CME/CEEngaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Sayna Norouzi, MD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CETranslating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
